SciELO - Scientific Electronic Library Online

 
vol.40 número6Obstrucción de sonda nasogástrica por molde de nutrición enteral índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

PROANO-FIERRO, María Esther; RODRIGUEZ-CANETE, Blanca Leticia; SANCHEZ-SOBRINO, Paula  y  REGO-IRAETA, Antonia. Hypophosphatemia associated with use of intravenous ferric carboxymaltose. Nutr. Hosp. [online]. 2023, vol.40, n.6, pp.1301-1304.  Epub 04-Mar-2024. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.04806.

Introduction:

ferric carboxymaltose (CF) is an intravenous preparation that helps the rapid correction of anemia with a lower risk of adverse reactions. However, an association has been found between the administration of CF and the development of hypophosphatemia.

Case report:

we present the clinical case of a 57-year-old patient with a history of iron de-ficiency anemia who, after receiving treatment with CF (Ferinjet®) chronically, develops a clinical of severe muscle weakness. Laboratory tests showed hypophosphatemia, normocalcemia, normal vitamin D level (after correction) and increased renal excretion of phosphorus. After study, the diagnosis of chronic hypophosphatemia secondary to the use of CF is reached.

Discussion:

CF can cause an increase in FGF-23 which acts at the renal level inducing phosphaturia, which can generate severe hypophosphatemia. This case demonstrates the importance of recognizing and treating this clinical entity in time.

Palabras clave : Hypophosphatemia; Ferric carboxymaltose; FGF-23; Phosphaturia.

        · resumen en Español     · texto en Español     · Español ( pdf )